Reuters Health News Summary

Following is a summary of current health news briefs. Eli Lilly seeks to quell drug price anger with cheaper insulin

Drugmaker Eli Lilly announced plans on Monday to sell a half-price version of its popular insulin injection Humalog, as it fends off criticism about rising drug prices in the United States. Major drugmakers including Lilly, a leading producer of insulin, have come under fire from patients and lawmakers over the rising cost of the life-saving medication used to treat diabetes. China urges crack down on concealing African swine fever: agriculture ministry

China needs to step up its prevention and control of African swine fever, said the agriculture ministry in a statement on Monday, as the disease continues to spread across the world's top pork-producing nation. Authorities should combat illegal activities such as concealing outbreaks, selling and arbitrarily disposing of sick and dead pigs, and feeding kitchen waste to pigs, said the ministry following a meeting with 18 other ministries. Kids with eczema may sleep poorly

Kids with eczema - even mild eczema - may be more likely to have poor quality sleep than children who don't have this common skin disorder, a UK study suggests. Eczema, also called atopic dermatitis, can lead to scaly, itchy rashes that keep kids up at night. But researchers don't have a clear picture of how eczema affects kids' ability to fall asleep, how often they awaken during the night, or how many total hours of rest they get. Ebola treatment center in Congo reopens after attack: ministry

An Ebola treatment center at the epicenter of the current outbreak in eastern Democratic Republic of Congo has resumed operations after it was closed in response to an attack last week, the Congolese health ministry said on Sunday. The facility in the city of Butembo was one of two centers torched by unknown assailants in the space of a few days, prompting Medecins Sans Frontieres (MSF) to suspend medical activities. U.S. seeks to cut dialysis costs with more home care versus clinics

The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost care at home and transplants, a change that would upend a dialysis industry that provides care in thousands of clinics nationwide. The goal is to reduce the $114 billion paid by the U.S. government each year to treat chronic kidney disease and end-stage renal disease, a top area of spending.